Technological offer

In vitro method to classify test compounds as hallucinogenic or non-hallucinogenic by measuring phosphorylation biomarkers and/or a metabolic readout in neural cultures.

Analysis of TAF1 isoforms in blood and cerebrospinal fluid of controls and individuals with Multiple Sclerosis.

Low-cost method with high effectiveness for the diagnosis and prognosis of thyroid cancers that are difficult to resolve during preoperative evaluation. It provides a malignancy score measuring the methylation level of various CpG sites determined by a machine learning classification system.

Immunochemical method for diagnosis of infections produced by Pseudomonas aeruginosa targeting the main signalling molecules of the pqs Quorum Sensing system. The immunoassay is fast and efficient, with low LOD and adaptable to point-of-care devices.

Early and accurate diagnosis and follow up of diseases related to cystine accumulation, such as cystinosis and cystinuria, based on a molecular network producing a signal measurable by fluorescence when certain substances bind to cysteine or cystine, allowing abnormal levels of cystine to be detected.